abstract |
The present invention relates to a nucleic acid construct and a recombinant influenza virus unable to multiply for inducing the expression of an immunomodulatory protein in a host and being of use in the development of vaccines against infectious diseases, particularly those caused by the influenza virus and coronavirus. |